Special concerns for survivors of prostate cancer
Peterson, A.C.
Clinical Advances in Hematology and Oncology H&o 14(9): 674-676
2016
ISSN/ISBN: 1543-0790 PMID: 27673285 Document Number: 690540
Document emailed within 1 workday
Related Documents
Arap, W. 2008: Quality of life and satisfaction with outcome among prostate-cancer survivors New England Journal of Medicine 359(2): 200Patel, A.; MacLeod, R.; Masters, J.; Keogh, J. 2014: Falling through the cracks: New Zealand prostate cancer survivors' experiences and views regarding PSA testing New Zealand Medical Journal 127(1400): 106-109
Moraska, A.R.; Atherton, P.J.; Szydlo, D.W.; Barton, D.L.; Stella, P.J.; Rowland, K.M.; Schaefer, P.L.; Krook, J.; Bearden, J.D.; Loprinzi, C.L. 2010: Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB Journal of Supportive Oncology 8(3): 128-132
Paterson, C.; Jones, M.; Rattray, J.; Lauder, W. 2013: Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society 17(6): 750-759
Bissada, N.K. 1994: Special issue: prostate cancer. Introduction Journal of the South Carolina Medical Association 90(5): 209
Hodgkinson, K.; Butow, P.; Hunt, G.E.; Pendlebury, S.; Hobbs, K.M.; Lo, S.K.; Wain, G. 2007: The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure) Psycho-Oncology 16(9): 796-804
Drake, B.F.; Keane, T.E.; Mosley, C.M.; Adams, S.Arp.; Elder, K.T.; Modayil, M.V.; Ureda, J.R.; Hebert, J.R. 2006: Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology Journal of the South Carolina Medical Association 102(7): 241-249
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Brown, S. 2013: Customized solutions for your special concerns--Part i West Virginia Medical Journal 109(5): 42-43
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
DeWitt, D.E.; Ostergaard, D. 1983: Traveling with lung disease. The special problems and concerns Postgraduate Medicine 74(5): 333-334
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Tewari, D.D. 1994: Developing and sustaining nontimber forest products: policy issues and concerns with special reference to India Journal of World Forest Resource Management 7(2): 151-178